TrialLipids in health and disease2017

Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects.

Kentaro Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.